Page 34 | Certara

Publication

Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease

Pompe disease is a rare and complex condition with severe infantile-onset (IOPD) and late-onset (LOPD)…

CertaraDecember 4, 2024

On-Demand Webinar

GlobalSubmit eCTD 4.0 Webinars

The world of electronic regulatory submissions is about to change with the introduction of eCTD…

CertaraDecember 3, 2024

Blog

CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know

December 3, 2024 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for…

CertaraDecember 3, 2024

Press Release

Certara Showcases 2024 Research Wins with Over 100 Papers Published

The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list …

CertaraDecember 2, 2024

Press Coverage

Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Published: November 27, 2024 Recent decades have seen continuing declines in pharmaceutical R&D productivity. Inflation…

CertaraNovember 27, 2024

Announcement

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Radnor, PA – November 25, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraNovember 25, 2024

eBook

PK/PD Data Analysis, Concepts and Applications eBook

Accelerate your Journey: Learn & Grow with the Standard Book for PK Scientists

CertaraNovember 25, 2024

Fact Sheet

Automated Writing Without the Compromise

CertaraNovember 22, 2024

Poster

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

CertaraNovember 22, 2024

Poster

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

CertaraNovember 22, 2024

Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease

GlobalSubmit eCTD 4.0 Webinars

CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know

Certara Showcases 2024 Research Wins with Over 100 Papers Published

Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

PK/PD Data Analysis, Concepts and Applications eBook

Automated Writing Without the Compromise

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

Newsletter sign up

Quick links

Solutions

Contact